Transcriptomic analyses of patient peripheral blood with hemoglobin depletion reveal glioblastoma biomarkers

Abstract Peripheral blood is gaining prominence as a noninvasive alternative to tissue biopsy to develop biomarkers for glioblastoma (GBM); however, widely utilized blood-based biomarkers in clinical settings have not yet been identified due to the lack of a robust detection approach. Here, we descr...

Full description

Bibliographic Details
Main Authors: Dan Qi, Yiqun Geng, Jacob Cardenas, Jinghua Gu, S. Stephen Yi, Jason H. Huang, Ekokobe Fonkem, Erxi Wu
Format: Article
Language:English
Published: Nature Portfolio 2023-01-01
Series:npj Genomic Medicine
Online Access:https://doi.org/10.1038/s41525-022-00348-3
_version_ 1811175734157246464
author Dan Qi
Yiqun Geng
Jacob Cardenas
Jinghua Gu
S. Stephen Yi
Jason H. Huang
Ekokobe Fonkem
Erxi Wu
author_facet Dan Qi
Yiqun Geng
Jacob Cardenas
Jinghua Gu
S. Stephen Yi
Jason H. Huang
Ekokobe Fonkem
Erxi Wu
author_sort Dan Qi
collection DOAJ
description Abstract Peripheral blood is gaining prominence as a noninvasive alternative to tissue biopsy to develop biomarkers for glioblastoma (GBM); however, widely utilized blood-based biomarkers in clinical settings have not yet been identified due to the lack of a robust detection approach. Here, we describe the application of globin reduction in RNA sequencing of whole blood (i.e., WBGR) and perform transcriptomic analysis to identify GBM-associated transcriptomic changes. By using WBGR, we improved the detection sensitivity of informatic reads and identified differential gene expression in GBM blood. By analyzing tumor tissues, we identified transcriptomic traits of GBM blood. Further functional enrichment analyses retained the most changed genes in GBM. Subsequent validation elicited a 10-gene panel covering mRNA, long noncoding RNA, and microRNA (i.e., GBM-Dx panel) that has translational potential to aid in the early detection or clinical management of GBM. Here, we report an integrated approach, WBGR, with comprehensive analytic capacity for blood-based marker identification.
first_indexed 2024-04-10T19:41:42Z
format Article
id doaj.art-2c57a57891044956bca3ec4bc011a2a7
institution Directory Open Access Journal
issn 2056-7944
language English
last_indexed 2024-04-10T19:41:42Z
publishDate 2023-01-01
publisher Nature Portfolio
record_format Article
series npj Genomic Medicine
spelling doaj.art-2c57a57891044956bca3ec4bc011a2a72023-01-29T12:18:04ZengNature Portfolionpj Genomic Medicine2056-79442023-01-018111310.1038/s41525-022-00348-3Transcriptomic analyses of patient peripheral blood with hemoglobin depletion reveal glioblastoma biomarkersDan Qi0Yiqun Geng1Jacob Cardenas2Jinghua Gu3S. Stephen Yi4Jason H. Huang5Ekokobe Fonkem6Erxi Wu7Department of Neurosurgery and Neuroscience Institute, Baylor Scott & White HealthDepartment of Neurosurgery and Neuroscience Institute, Baylor Scott & White HealthBaylor Scott & White Research InstituteBaylor Scott & White Research InstituteInstitute for Cellular and Molecular Biology (ICMB), College of Natural Sciences, The University of Texas at AustinDepartment of Neurosurgery and Neuroscience Institute, Baylor Scott & White HealthDepartment of Neurosurgery and Neuroscience Institute, Baylor Scott & White HealthDepartment of Neurosurgery and Neuroscience Institute, Baylor Scott & White HealthAbstract Peripheral blood is gaining prominence as a noninvasive alternative to tissue biopsy to develop biomarkers for glioblastoma (GBM); however, widely utilized blood-based biomarkers in clinical settings have not yet been identified due to the lack of a robust detection approach. Here, we describe the application of globin reduction in RNA sequencing of whole blood (i.e., WBGR) and perform transcriptomic analysis to identify GBM-associated transcriptomic changes. By using WBGR, we improved the detection sensitivity of informatic reads and identified differential gene expression in GBM blood. By analyzing tumor tissues, we identified transcriptomic traits of GBM blood. Further functional enrichment analyses retained the most changed genes in GBM. Subsequent validation elicited a 10-gene panel covering mRNA, long noncoding RNA, and microRNA (i.e., GBM-Dx panel) that has translational potential to aid in the early detection or clinical management of GBM. Here, we report an integrated approach, WBGR, with comprehensive analytic capacity for blood-based marker identification.https://doi.org/10.1038/s41525-022-00348-3
spellingShingle Dan Qi
Yiqun Geng
Jacob Cardenas
Jinghua Gu
S. Stephen Yi
Jason H. Huang
Ekokobe Fonkem
Erxi Wu
Transcriptomic analyses of patient peripheral blood with hemoglobin depletion reveal glioblastoma biomarkers
npj Genomic Medicine
title Transcriptomic analyses of patient peripheral blood with hemoglobin depletion reveal glioblastoma biomarkers
title_full Transcriptomic analyses of patient peripheral blood with hemoglobin depletion reveal glioblastoma biomarkers
title_fullStr Transcriptomic analyses of patient peripheral blood with hemoglobin depletion reveal glioblastoma biomarkers
title_full_unstemmed Transcriptomic analyses of patient peripheral blood with hemoglobin depletion reveal glioblastoma biomarkers
title_short Transcriptomic analyses of patient peripheral blood with hemoglobin depletion reveal glioblastoma biomarkers
title_sort transcriptomic analyses of patient peripheral blood with hemoglobin depletion reveal glioblastoma biomarkers
url https://doi.org/10.1038/s41525-022-00348-3
work_keys_str_mv AT danqi transcriptomicanalysesofpatientperipheralbloodwithhemoglobindepletionrevealglioblastomabiomarkers
AT yiqungeng transcriptomicanalysesofpatientperipheralbloodwithhemoglobindepletionrevealglioblastomabiomarkers
AT jacobcardenas transcriptomicanalysesofpatientperipheralbloodwithhemoglobindepletionrevealglioblastomabiomarkers
AT jinghuagu transcriptomicanalysesofpatientperipheralbloodwithhemoglobindepletionrevealglioblastomabiomarkers
AT sstephenyi transcriptomicanalysesofpatientperipheralbloodwithhemoglobindepletionrevealglioblastomabiomarkers
AT jasonhhuang transcriptomicanalysesofpatientperipheralbloodwithhemoglobindepletionrevealglioblastomabiomarkers
AT ekokobefonkem transcriptomicanalysesofpatientperipheralbloodwithhemoglobindepletionrevealglioblastomabiomarkers
AT erxiwu transcriptomicanalysesofpatientperipheralbloodwithhemoglobindepletionrevealglioblastomabiomarkers